Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02964520 · ClinicalTrials.gov registry record · NA

EEG Alpha/Theta Neurofeedback to Reduce Trait Anxiety

A NA study of Anxiety, sponsored by University of Hartford.

Completed
Registry status
NA
Development phase
28
Enrollment target
1
Study location

NCT02964520 is a NA study of Anxiety that has completed, run by University of Hartford. The registered enrollment target is 28 participants, below the 440-participant average among 364 other Anxiety trials with a reported enrollment target (94% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02964520, a NA study of Anxiety, has completed, sponsored by University of Hartford.

COMPLETED
Registry status
NA
Development phase
28 participants
Enrollment target
1
Study location

Study Summary

This study evaluates if individuals with moderate to high trait anxiety can learn how to self-regulate their brain waves and reduce their trait anxiety in ten sessions of EEG alpha-theta neurofeedback training. Half of the randomly assigned participants will receive alpha/theta neurofeedback training while the other half will receive a two-part control protocol where low beta and beta waves will be uptrained in and downtrained in in successive sessions.

Conditions Studied

Interventions

  • BEHAVIORAL Neurofeedback training
  • BEHAVIORAL Sham comparator: Sham neurofeedback training

Study Locations (1)

Connecticut

  • University of Hartford - West Hartford

Trial Details

FieldValue
Enrollment Target 28 participants
Start Date 2015-07
Est. Completion 2017-01
Phase NA

Sponsor

University of Hartford

14 total trials

What the Registry Record Tells You About NCT02964520

The ClinicalTrials.gov registry entry for NCT02964520 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 28 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 440-participant average among 364 other Anxiety trials with a reported enrollment target (94% lower). The listed sponsor is University of Hartford, which has 14 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Anxiety appearing as the primary indexed condition, and to 2 interventions - of which Neurofeedback training is the first listed.

NCT02964520 reports 1 study location spanning 1 distinct geographic area - top geographies include Connecticut.

Frequently Asked Questions

What is clinical trial NCT02964520 about?

NCT02964520 is a clinical study titled "EEG Alpha/Theta Neurofeedback to Reduce Trait Anxiety". This study evaluates if individuals with moderate to high trait anxiety can learn how to self-regulate their brain waves and reduce their trait anxiety in ten sessions of EEG alpha-theta neurofeedback training. Half of the randomly assigned participants will receive alpha/theta neurofeedback trainin...

What is the current status of trial NCT02964520?

This trial is currently completed. It is a NA study. The enrollment target is 28 participants. The study started on 2015-07. Estimated completion is 2017-01.

What conditions does trial NCT02964520 study?

This clinical trial studies the following conditions: Anxiety.

What interventions are being tested in trial NCT02964520?

The interventions under investigation include: Neurofeedback training (BEHAVIORAL), Sham comparator: Sham neurofeedback training (BEHAVIORAL).

Who is sponsoring clinical trial NCT02964520?

This trial is sponsored by University of Hartford, which has 14 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02964520 being conducted?

This trial has 1 study location across Connecticut. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Anxiety

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.